• Journal Article

Using an incremental net-benefit framework for quantitative benefit-risk analysis in regulatory decision making – a case study of alosetron in irritable bowel syndrome.

Citation

Lynd, L., Najafzadeh, M., Colley, L., Byrne, M., Willan, A., Sculpher, M., ... Hauber, A. (2010). Using an incremental net-benefit framework for quantitative benefit-risk analysis in regulatory decision making – a case study of alosetron in irritable bowel syndrome. Value in Health, 13(4), 411 - 7.

Abstract